← Leaderboards
Katherine Moxley
University Of Oklahoma Hlth Sciences Ctr
$650,601
Attributed
$650,601
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $217.5K · FY2018–20$250K$187.5K$125K$62.5K$0
'18
'19
'20
Funding mix
By agency
NIH$650,601 · 1
By mechanism
P20$650,601 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Oklahoma Hlth Sciences Ctr
Same institution · by research overlap
- Robert S Mannel$9,366,958
- Doris Mangiaracina Benbrook$6,963,868
- Priyabrata Mukherjee$10,375,168
- Resham Bhattacharya$4,398,302
- Kar-Ming Fung$3,379,440
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectBaseBioinformaticsAftercareBiological Adaptation To StressBiological MarkersBloodBody FluidsCancer BiomarkersCancer Cell LineCancer DetectionCancer PatientCell MembraneCell ProliferationCellsChemotherapyClinical AssessmentsCodeCohortColonic NeoplasmsCytotoxic ChemotherapyData SetDiagnosisDisease Progression
Grant awards (3)
Exosomes in Predicting Response to Chemotherapy in Metastatic Endometrial Carcinoma$216,227
P20 · FY2020 · GM · contact PI
Exosomes in Predicting Response to Chemotherapy in Metastatic Endometrial Carcinoma$216,874
P20 · FY2019 · GM · contact PI
Exosomes in Predicting Response to Chemotherapy in Metastatic Endometrial Carcinoma$217,500
P20 · FY2018 · GM · contact PI